Vera Therapeutics Announces Phase 3 Clinical Trial for Atacicept in Lupus Nephritis

NEXT STORY
Worldwide Clinical Trials and Science 37® Partner to Advance Agile Clinical Trials™ and Accelerate Study Timelines
PREV STORY
Resverlogix Announces Commencement of Patient Enrollment and Dosing in a Phase 2b Trial for a Promising Canadian-Developed COVID-19 Treatment
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

FIT Biotech Oy: FIT BIOTECH’S FINANCIAL CALENDAR IN 2018

FIT Biotech OyCompany release December 18, 2017 at 4 pm EET                                  FIT BIOTECH'S FINANCIAL ...

author_avatar
NASDAQ Market News

Soricimed Announces the Appointment of Dr. Marc Rubin and Mr. Vaughn Embro-Pantalony to Board of Directors

MONCTON, New Brunswick, March 19, 2018 (GLOBE NEWSWIRE) -- Soricimed Biopharma Inc. ("Soricimed"), a ...

author_avatar
NASDAQ Market News

Radius Health to Present at Morgan Stanley 15th Annual Global Healthcare Conference

WALTHAM, Mass., Sept. 07, 2017 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq:RDUS), a fully ...

author_avatar
NASDAQ Market News